πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7217541

Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigen

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7217418

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214787

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214524

Marek's disease virus vaccine

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208161

Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7204993

Streptococcus agalactiae vaccine

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7201907

Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7192588

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7192934

Vaccines for blocking transmission of Plasmodium vivax

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179888

Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies,

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7175848

Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolize

The Board of Regents of the University of Texas System Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7150984

Attenuated human rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7150875

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7132271

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7118758

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7112332

Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysac

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7097841

Ferritin fusion proteins for use in vaccines and other applications

New Century Pharmaceuticals, Inc. Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094597

Vaccine compositions and methods useful in inducing immune protection against arthritogeni

The Regents of the University of California Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7083787

Yeast-dendritic cell vaccines and uses thereof

The Regents of the University of Colorado Β· Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7081529

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7074410

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted